Clinical Trials on Idiopathic Pulmonary Hypertension
Total 19404 results
-
PhaseBio Pharmaceuticals Inc.TerminatedPulmonary Arterial HypertensionUnited States
-
University of PittsburghWithdrawn
-
BayerCompletedPulmonary Arterial HypertensionBelgium, France, Spain, Portugal, Turkey, United States, Germany, Korea, Republic of, Mexico, Austria, Canada, Denmark, Poland, Italy, Greece, Taiwan, Czechia, Netherlands, Japan, Brazil, United Kingdom
-
PhaseBio Pharmaceuticals Inc.CompletedPulmonary Arterial HypertensionUnited States
-
National Health Service, United KingdomCompletedPulmonary Arterial HypertensionUnited Kingdom
-
United TherapeuticsTerminatedPulmonary Arterial HypertensionAustralia
-
ActelionCompletedPulmonary Arterial HypertensionUnited States
-
Northwell HealthCompletedPulmonary Arterial HypertensionUnited States
-
University of FloridaUnited TherapeuticsTerminatedChronic Obstructive Pulmonary Disease | Pulmonary Arterial HypertensionUnited States
-
Acceleron Pharma, Inc., a wholly-owned subsidiary...RecruitingPulmonary Arterial Hypertension | PAHUnited States, France, Germany, Spain, Sweden, Argentina, Australia, Austria, Colombia, Croatia, Denmark, Greece, Israel, Italy, Korea, Republic of, Netherlands, New Zealand, Portugal, Serbia, Taiwan, United Kingdom, Brazil, Canada, B... and more
-
Chinese Pulmonary Vascular Disease Research GroupRecruitingPulmonary Hypertension | Chronic Thromboembolic Pulmonary Hypertension | Pulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder)China
-
University of California, Los AngelesBayerRecruiting
-
Bastiaan DriehuysRecruitingPulmonary Arterial Hypertension | Pulmonary HypertensionUnited States
-
Magdi H. YacoubRecruitingPulmonary HypertensionEgypt
-
University of PennsylvaniaJohns Hopkins University; University of Colorado, Denver; Washington University... and other collaboratorsCompletedPulmonary Arterial HypertensionUnited States
-
United TherapeuticsCompletedPulmonary HypertensionUnited States, China, Israel, Belgium, Canada, France, India, Mexico, Austria, Italy, Netherlands, Poland, Puerto Rico
-
BayerCompletedPulmonary HypertensionBelgium, France, Spain, China, United States, Turkey, New Zealand, Portugal, Taiwan, Japan, Australia, Singapore, Argentina, Sweden, Switzerland, Mexico, Austria, Thailand, Canada, Denmark, Germany, Israel, Russian Federation, Italy, Korea... and more
-
University of CalgaryUniversity of SaskatchewanWithdrawnPulmonary HypertensionCanada
-
University of Colorado, DenverCompleted
-
Assistance Publique - Hôpitaux de ParisBayer; Technion, Israel Institute of TechnologyCompletedPulmonary HypertensionFrance
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedPulmonary HypertensionJapan
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedPulmonary HypertensionUnited States, Netherlands, Belgium, Spain, Hungary, Germany, South Africa, Italy, United Kingdom, Australia, Poland, Korea, Republic of, Malaysia, Brazil, Czechia, Denmark, Israel, Singapore, Mexico, Sweden, France, Hong Kong
-
United TherapeuticsTerminatedPulmonary Hypertension Associated With HFpEFUnited States
-
Elpen Pharmaceutical Co. Inc.Withdrawn
-
Medical University of GrazLudwig Boltzmann GesellschaftCompletedPulmonary Arterial HypertensionAustria
-
University of Alabama at BirminghamCompletedPulmonary Arterial HypertensionUnited States
-
Northwell HealthCompletedPulmonary Arterial HypertensionUnited States
-
Gilead SciencesCompletedPulmonary HypertensionUnited States, Australia, Canada
-
Tongji UniversityCompletedPulmonary HypertensionChina
-
Gilead SciencesCompletedPulmonary HypertensionUnited States, Germany, Australia, Belgium, France, Italy
-
Keros Therapeutics, Inc.RecruitingPulmonary Arterial HypertensionUnited States, Australia
-
Novartis PharmaceuticalsRecruitingPulmonary Arterial HypertensionSpain, Germany, Netherlands, Poland, United Kingdom, Argentina, United States
-
University of Kansas Medical CenterAmerican Heart AssociationRecruitingPulmonary Arterial HypertensionUnited States
-
China-Japan Friendship HospitalRecruitingChronic Thromboembolic Pulmonary HypertensionChina
-
Nanjing First Hospital, Nanjing Medical UniversityTianjin Medical University General HospitalRecruitingPulmonary Arterial HypertensionChina
-
University of Texas Southwestern Medical CenterRecruitingPulmonary Arterial HypertensionUnited States
-
Laval UniversityCanadian Institutes of Health Research (CIHR); Resverlogix CorpNot yet recruiting
-
ActelionRecruitingPulmonary Arterial HypertensionBelgium, United States, Italy, Canada, Taiwan, Greece, China, Korea, Republic of, Germany, Israel, Austria, Russian Federation, Australia, Thailand, United Kingdom, Brazil, Malaysia, Spain, Ukraine, Bulgaria, Colombia, Mexico, Turkey, Vietna... and more
-
Janssen-Cilag S.p.A.CompletedPulmonary Arterial HypertensionItaly
-
Merck Sharp & Dohme LLCActive, not recruitingPulmonary Arterial HypertensionJapan
-
Novartis PharmaceuticalsActive, not recruitingPulmonary Arterial HypertensionUnited States, Spain, Germany, Poland, United Kingdom, Netherlands, Argentina
-
United TherapeuticsCompletedPulmonary Arterial Hypertension
-
United TherapeuticsCompletedPulmonary Arterial HypertensionUnited States
-
ActelionCompletedPulmonary Arterial HypertensionUnited States, Poland, Ukraine, United Kingdom, China, Germany, Taiwan, France, Spain, Switzerland, Argentina, Belarus, Belgium, Colombia, Israel, India, Malaysia, Romania, Serbia, Canada, Australia, Netherlands, Denmark, Greece, Korea,... and more
-
Acceleron Pharma Inc. (a wholly owned subsidiary...CompletedPulmonary Arterial HypertensionSpain, United States, Israel, Australia, Germany, United Kingdom, France, Brazil
-
Eiger BioPharmaceuticalsTerminatedPulmonary Arterial HypertensionUnited States, Canada
-
Vigonvita Life SciencesShanghai Institute of Materia Medica, Chinese Academy of SciencesCompletedPulmonary Arterial HypertensionChina
-
International CTEPH AssociationCompletedChronic Thromboembolic Pulmonary Hypertension | CTEPHUnited States, Japan, Belgium, United Kingdom, Netherlands, Czechia, Germany, Austria, France, Poland
-
United TherapeuticsCompletedAn Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial HypertensionPulmonary Arterial HypertensionKorea, Republic of, United States, Australia, Austria, Taiwan, China, Israel, Canada, India, Germany, Singapore, United Kingdom, Brazil, Italy, Netherlands, Argentina, Sweden, Chile, Denmark, France, Greece, Mexico, Poland